Equity Analysis /
United States of America

US : InflaRx N.V. - IFRX | FDA: "Oops, nevermind" (Paraphrased)

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    25 March 2022
    Published by